Prosecution Insights
Last updated: April 19, 2026

Examiner: DICKENS, AMELIA NICOLE

Tech Center 1600 • Art Units: 1645

This examiner grants 48% of resolved cases

Performance Statistics

47.6%
Allow Rate
-12.4% vs TC avg
148
Total Applications
+20.8%
Interview Lift
1310
Avg Prosecution Days
Based on 103 resolved cases, 2023–2026

Rejection Statute Breakdown

7.9%
§101 Eligibility
20.2%
§102 Novelty
20.0%
§103 Obviousness
33.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18016432 RECOMBINANT MICROORGANISMS Final Rejection The Regents of the University of California
17788224 PROCESS TO IDENTIFY CONSORTIA OF PROBIOTIC STRAINS SUITABLE FOR GLUTEN DEGRADATION Non-Final OA Evonik Operations GmbH
17335578 METHODS FOR ASSESSING EFFICACY OF A DRUG IN VIVO BY MONITORING ADME PROTEINS IN EXTRACELLULAR VESICLES Final Rejection Purdue Research Foundation
17969632 USE OF VIRUS-LIKE PARTICLES INCLUDING TOXOPLASMA GONDII APICAL MEMBRANE ANTIGEN 1 FOR SERODIAGNOSING TOXOPLASMOSIS Final Rejection University-Industry Cooperation Group of Kyung Hee University
18457299 RECOMBINANT MICROORGANISMS AND USES THEREFOR Non-Final OA LanzaTech, Inc.
18018526 ACTINOBACILLUS PLEUROPNEUMONIAE VACCINES Non-Final OA Ceva Sante Animale
18949811 APPLICATION OF T1FR PROTEIN IN INHIBITION OF PATHOGENICITY OF ADHERENT-INVASIVE ESCHERICHIA COLI (AIEC) Non-Final OA Sichuan University
18604196 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING NEURODEGENERATIVE DISEASES Final Rejection MarvelBiome, Inc.
18545629 GENETICALLY MODIFIED FUNGAL CELLS AND METHODS USEFUL FOR PRODUCING PRESPATANE Final Rejection NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC
18328308 ANTAGONIST MICROORGANISMS FOR INHIBITING FIRE BLIGHT AND COMPOSITION FOR INHIBITING FIRE BLIGHT WITH THE SAME AS ACTIVE INGREDIENT Final Rejection KNU-INDUSTRY COOPERATION FOUNDATION
18392130 ANTIMICROBIAL PEPTIDES AND MODIFICATIONS THEREOF Non-Final OA Donald Danforth Plant Science Center
17633993 OPTIMIZED CULTURE MEDIA FOR CLOSTRIDIA BACTERIA Non-Final OA Janssen Biotech, Inc.
18161617 METHODS AND COMPOSITIONS FOR TREATING METABOLIC CONDITIONS Non-Final OA KEMIN INDUSTRIES, INC.
18675831 TREATING OR PREVENTING RESPIRATORY INFECTION Non-Final OA Telethon Kids Institute
17616409 COMPOSITION CONTAINING A YEAST FOR PREVENTING SIMPLE AND/OR RECURRING CYSTITIS Non-Final OA LESAFFRE ET COMPAGNIE
18029640 COMPOSITIONS COMPRISING INACTIVATED MICROBES, AND METHODS FOR USE AND PRODUCTION THEREOF Final Rejection Colorado State University Research Foundation
18266167 COMPOSITION COMPRISING BACTERIUM OF THE GENUS ACIDIPROPIONIBACTERIUM OR PROCESSED PRODUCT THEREOF Non-Final OA MEIJI CO., LTD.
18691412 RECOMBINANT GLYCAN BINDING PROTEINS AND ITS USE Non-Final OA UNICHEM LABORATORIES LIMITED
17927139 A LIVE STRAIN OF STAPHYLOCOCCUS AUREUS AND USES THEREOF Final Rejection Versitech Limited
18555540 BACILLUS SUBTILIS FNFH_BS08 AND USE THEREOF Non-Final OA ZHEJIANG OCEAN UNIVERSITY
18367513 RATIONAL DESIGN OF MICROBIAL-BASED BIOTHERAPEUTICS Non-Final OA Gusto Global, LLC
18027351 COMPOSITION FOR PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE COMPRISING LACTOBACILLUS SAKEI PROBIO-65 Non-Final OA PROBIONIC INC.
18245446 PARABACTEROIDES DISTASONIS STRAINS FOR USE THEREOF IN THE TREATMENT AND PREVENTION OF GASTROINTESTINAL DISEASES AND OF DISORDERS ASSOCIATED WITH GASTROINTESTINAL DISEASES Non-Final OA INSTITUT NATIONAL DES SCIENCES ET INDUSTRIES DU VIVANT ET DE L'ENVIRONNEMENT
17768138 Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof Non-Final OA ACARYON GMBH
17435615 ANTIBODY MOLECULES AND USES THEREOF Non-Final OA THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN
16329538 METHODS OF IDENTIFYING EPITOPES Final Rejection OBLIQUE THERAPEUTICS AB

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month